AssayIndex
Reports by quarter

Reports submitted in 2025-Q4 · page 5

Provenance classification became a required field. Median purity for the quarter is 99.12 % area, n=762. Read the 2025-Q4 state-of-the-index report →

762 records20 pagesmedian on this page 99.19 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-018593BPC-157QYBQYB-2508-M5189Kestrel2025-Q499.934.6390.8Supplier-supplied0PASS
AX-2025-018564TirzepatideQYBQYB-2507-T4628Nordanalyt2025-Q499.356.61—Buyer-sourced0PASS
AX-2025-018532GHRP-2QYBQYB-2510-D4215PeptideMeter2025-Q499.304.2688.8Buyer-sourced1MARGINAL
AX-2025-018530ARA-290QYBQYB-2511-Y4275Janoshik2025-Q499.515.1791.1Buyer-sourced0PASS
AX-2025-021088CagrilintideBCHBCH-2509-A4594Janoshik2025-Q499.905.8197.9Supplier-supplied0PASS
AX-2025-021048GonadorelinBCHBCH-2510-F4167Medutest2025-Q498.575.68104.3Buyer-sourced0PASS
AX-2025-020404BPC-157MKMMKM-2506-D4138VendorInvestigate2025-Q498.543.44—Buyer-sourced0PASS
AX-2025-020174Kisspeptin-10ERPERP-2508-R9614VendorInvestigate2025-Q498.864.3894.2Buyer-sourced0PASS
AX-2025-020061SelankSWBSWB-2511-C7797Nordanalyt2025-Q499.219.29—Buyer-sourced0PASS
AX-2025-019562MK-677 (Ibutamoren mesylate)TFCTFC-2511-N1358Janoshik2025-Q499.123.5089.3Buyer-sourced1FAIL
AX-2025-019484SS-31 (Elamipretide)JEEPJEEP-2511-B8241Medutest2025-Q499.194.74107.4Buyer-sourced1MARGINAL
AX-2025-019122AOD-9604GSPGSP-2505-S3921Janoshik2025-Q498.434.1994.6Buyer-sourced0PASS
AX-2025-018986Enclomiphene citrateASYASY-{CAT}-1806Medutest2025-Q499.933.35—Buyer-sourced1FAIL
AX-2025-018553RetatrutideQYBQYB-2507-R4727Janoshik2025-Q498.213.81—Buyer-sourced0PASS
AX-2025-018431GHRP-6WWBWWB-2511-C2485Janoshik2025-Q499.794.63105.2Buyer-sourced1MARGINAL
AX-2025-020810GHRP-6CPCCPC-2507-G1030Janoshik2025-Q499.856.33—Buyer-sourced0PASS
AX-2025-020383PT-141 (Bremelanotide)MKMMKM-2509-B4043PeptideMeter2025-Q499.735.6990.6Buyer-sourced0PASS
AX-2025-020126IpamorelinERPERP-2505-U8938Medutest2025-Q499.624.09100.7Buyer-sourced1MARGINAL
AX-2025-020075IGF-1 LR3SWBSWB-2505-N7884Janoshik2025-Q497.586.05—Buyer-sourced0PASS
AX-2025-019555SemaglutideTFCTFC-2507-U1178Janoshik2025-Q498.964.47103.5Buyer-sourced1MARGINAL
AX-2025-019023PramlintideASYASY-{CAT}-2288Janoshik2025-Q498.954.38102.5Buyer-sourced0PASS
AX-2025-018973OxytocinASYASY-{CAT}-1898Janoshik2025-Q499.933.8093.5Buyer-sourced0PASS
AX-2025-021044GonadorelinBCHBCH-2510-F4167Janoshik2025-Q498.895.51—Buyer-sourced0PASS
AX-2025-020493BPC-157KPKP-2511-M5901VendorInvestigate2025-Q498.615.34—Buyer-sourced0PASS
AX-2025-020083MazdutideSWBSWB-2505-Y7982VendorInvestigate2025-Q498.143.25101.4Buyer-sourced0PASS
AX-2025-019793MK-677 (Ibutamoren mesylate)HomopeptideHOMO-2506-L4686Janoshik2025-Q499.511.23—Buyer-sourced0FAIL
AX-2025-019792MK-677 (Ibutamoren mesylate)HomopeptideHOMO-2506-L4686Janoshik2025-Q499.891.4095.5Buyer-sourced0FAIL
AX-2025-019710RetatrutideHomopeptideHOMO-2508-Y3248Janoshik2025-Q498.347.11100.9Buyer-sourced0PASS
AX-2025-019439BPC-157JEEPJEEP-2511-V7760Janoshik2025-Q499.783.01100.5Buyer-sourced0PASS
AX-2025-019020PramlintideASYASY-{CAT}-2288VendorInvestigate2025-Q499.185.11106.8Buyer-sourced0PASS
AX-2025-018981OxytocinASYASY-{CAT}-1898Janoshik2025-Q499.933.40101.6Buyer-sourced0PASS
AX-2025-018792SemaglutideFGPFGP-2506-J7851Kestrel2025-Q499.934.44105.8Buyer-sourced1MARGINAL
AX-2025-018791SemaglutideFGPFGP-2506-J7851VendorInvestigate2025-Q499.934.5491.2Buyer-sourced1MARGINAL
AX-2025-018562TirzepatideQYBQYB-2507-T4628Janoshik2025-Q499.155.8493.0Buyer-sourced1MARGINAL
AX-2025-018489CJC-1295 with DACWWBWWB-2509-J2816PeptideMeter2025-Q498.873.5293.5Buyer-sourced0PASS
AX-2025-021047GonadorelinBCHBCH-2510-F4167Janoshik2025-Q499.075.56—Buyer-sourced0PASS
AX-2025-020266CJC-1295 (no DAC)GGPepsGGPE-2507-D1397Medutest2025-Q498.084.3995.0Buyer-sourced0PASS
AX-2025-020136TB-500ERPERP-2511-L9306VendorInvestigate2025-Q498.895.1788.7Buyer-sourced2MARGINAL
AX-2025-018716TB-500QSCQSC-2507-J6496Medutest2025-Q499.935.67—Buyer-sourced0PASS
AX-2025-018486CJC-1295 with DACWWBWWB-2509-J2816PeptideMeter2025-Q498.883.33—Buyer-sourced0PASS